No evidence that GATA3 rs570613 SNP modifies breast cancer risk
Shirley Hodgson(St Thomas' Hospital), Jackie Cook(Sheffield Children's Hospital), Hiltrud Brauch(German Cancer Research Center), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust), Christian F. Singer(Comprehensive Cancer Center Vienna), Fergus J. Couch(Mayo Clinic), Graham G. Giles(The University of Melbourne), John L. Hopper(The University of Melbourne), Daphne Gschwantler‐Kaulich(Medical University of Vienna), A. Fink-Retter(Mayo Clinic), Noralane M. Lindor(Mayo Clinic in Arizona), Andrew K. Godwin(The University of Melbourne), Kamila Czene(Karolinska Institutet), Per Hall(Karolinska Institutet), Heli Nevanlinna(University of Helsinki), Christina Justenhoven(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Carl Blomqvist(University of Helsinki), Susan M. Domchek(University City Science Center), Kirsimari Aaltonen(University of Helsinki), Katherine L. Nathanson(Translational Therapeutics (United States)), Carol Chu(Lyon 1 Université), Tuomas Heikkinen(University of Helsinki), D. Gareth Evans(Manchester Academic Health Science Centre), Robert F. Tarrell(University of Cambridge), V. Shane Pankratz(University of New Mexico), Melissa C. Southey(The University of Melbourne), Jianjun Liu(University of Kentucky), Ute Hamann(German Cancer Research Center), Trevor Cole(Birmingham Women's Hospital), Margaret Cook(Cancer Research UK), Amanda B. Spurdle(QIMR Berghofer Medical Research Institute), Sharon E. Johnatty(University of Southern California), Gabriella Pichert(Guy's Hospital), Kristiina Aittomäki(University of Helsinki), Fiona Douglas(University of Southern California), Zachary Fredericksen(Karolinska University Hospital), Radka Platte(University of Cambridge), Rosemarie Davidson(The Netherlands Cancer Institute), Yon‐Dschun Ko(University of Bonn), Susan Peock(Cancer Research UK), Fiona Lalloo(Manchester Academic Health Science Centre), Jonathan Beesley(QIMR Berghofer Medical Research Institute), Maria A. Caligo(Azienda Ospedaliera Universitaria Pisana), Diana Eccles(Princess Anne Hospital)
Cited by 12
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Analysis of shared heritability in common disorders of the brain
|Science|2018|2k